Xiangyan F. Liu

324 Jingwu Road
Jinan, 250021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Combined handgrip strength and incident chronic digestive diseases: a prospective parallel analysis examining broad and specific endpoints in Chinese and European older adults.

Combined handgrip strength and incident chronic digestive diseases: a prospective parallel analysis examining broad and specific endpoints in Chinese and European older adults.

Journal: Global health action

Published: June 15, 2026

Remnant cholesterol inflammatory index and chronic lung disease in middle-aged and older Chinese adults: A cross-sectional analysis of the China Health and Retirement Longitudinal Study.

Remnant cholesterol inflammatory index and chronic lung disease in middle-aged and older Chinese adults: A cross-sectional analysis of the China Health and Retirement Longitudinal Study.

Journal: Medicine

Published: February 07, 2026

Risk factors analysis and prediction models of atrial fibrillation/flutter after esophagectomy.

Risk factors analysis and prediction models of atrial fibrillation/flutter after esophagectomy.

Journal: Journal of cardiothoracic surgery

Published: September 10, 2025

Engineered anti-cancer nanomedicine for synergistic cuproptosis-immunotherapy.

Engineered anti-cancer nanomedicine for synergistic cuproptosis-immunotherapy.

Journal: Materials today. Bio

Published: May 20, 2025

Characterization of balance function during the interictal period of vertigo attacks in patients with Ménière's disease

Characterization of balance function during the interictal period of vertigo attacks in patients with Ménière's disease

Journal: Zhonghua yi xue za zhi

Published: May 08, 2025

HOXA5 Derives the Malignant Progression and Cisplatin Resistance of Esophageal Squamous Cell Carcinoma by Regulating USP18-Mediated IFI27 Deubiquitination.

HOXA5 Derives the Malignant Progression and Cisplatin Resistance of Esophageal Squamous Cell Carcinoma by Regulating USP18-Mediated IFI27 Deubiquitination.

Journal: Thoracic cancer

Published: October 29, 2024

Inhibition of esophageal squamous cell carcinoma progression by MIR210HG and activation of the P53 signaling pathway to promote apoptosis and autophagy.

Inhibition of esophageal squamous cell carcinoma progression by MIR210HG and activation of the P53 signaling pathway to promote apoptosis and autophagy.

Journal: European journal of medical research

Published: October 27, 2024

SLC25A1 promotes lymph node metastasis of esophageal squamous cell carcinoma by regulating lipid metabolism.

SLC25A1 promotes lymph node metastasis of esophageal squamous cell carcinoma by regulating lipid metabolism.

Journal: International journal of oncology

Published: August 07, 2024

NUPR1 induces autophagy and promotes the progression of Esophageal squamous cell carcinoma via the MAPK-mTOR pathway.

NUPR1 induces autophagy and promotes the progression of Esophageal squamous cell carcinoma via the MAPK-mTOR pathway.

Journal: Pathology, research and practice

Published: November 13, 2023

MUC1 promotes lymph node metastasis in esophageal squamous cell carcinoma by downregulating DNAJB6 expression.

MUC1 promotes lymph node metastasis in esophageal squamous cell carcinoma by downregulating DNAJB6 expression.

Journal: Environmental toxicology

Published: March 31, 2023

TRIM36 enhances lung adenocarcinoma radiosensitivity and inhibits tumorigenesis through promoting RAD51 ubiquitination and antagonizing hsa-miR-376a-5p.

TRIM36 enhances lung adenocarcinoma radiosensitivity and inhibits tumorigenesis through promoting RAD51 ubiquitination and antagonizing hsa-miR-376a-5p.

Journal: Biochemical and biophysical research communications

Published: August 03, 2022

Downregulation of fibulin-4 inhibits autophagy and promotes the sensitivity of esophageal squamous cell carcinoma cells to apatinib by activating the Akt-mTOR signaling pathway.

Downregulation of fibulin-4 inhibits autophagy and promotes the sensitivity of esophageal squamous cell carcinoma cells to apatinib by activating the Akt-mTOR signaling pathway.

Journal: Thoracic cancer

Published: May 29, 2022

Showing 1-12 of 47

Last Updated: 09/26/2026